Revolutionary Mass Spectrometer Set to Transform Biological Discovery

Thermo Fisher Scientific Inc has introduced the Thermo Scientific™ Orbitrap™ Astral™ mass spectrometer. Representing a major leap forward in the field, this cutting-edge analyser offers unprecedented capabilities, combining rapid throughput, exceptional sensitivity, and deep proteome coverage. Researchers across the globe can now uncover elusive proteins that were previously undetectable, enabling them to achieve ground-breaking discoveries with greater efficiency. This invaluable information opens up new avenues for identifying clinical biomarkers, detecting diseases at an earlier stage, and developing innovative interventions for a wide range of conditions, including cardiovascular diseases and cancer.

The advancements in genomics have provided significant knowledge about various diseases. However, proteomics takes this research a step further by providing additional insights into the intricate and ever-changing cellular processes. This expansion of understanding enables the development of novel drugs and diagnostics that can have a substantial impact on human health.

With the Astral analyser, Thermo Fisher enhances its renowned Orbitrap mass spectrometry platform with innovative technology. This game-changing instrument offers unparalleled capabilities, providing up to twice the depth of proteome coverage and up to four times the throughput compared to existing mass spectrometers. With its exceptional performance, the Astral analyzer empowers researchers to delve even deeper into the intricacies of cellular processes, paving the way for the discovery of new therapeutic interventions and advanced diagnostic tools.

More information online